【レポートの概要（一部）】
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
• Key buying criteria
PART 05: Cardiovascular drugs market
• Global pharmaceuticals market
• Global cardiovascular drugs market
PART 06: Overview: Hypertension
• Systemic hypertension
• PAH
PART 07: Epidemiology and economic burden
• Economic burden
PART 08: Pipeline portfolio
PART 09: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 10: Market segmentation by type
• Global systemic hypertension drugs market
• Global PAH drugs market
PART 11: Market segmentation by drug class
• Systemic hypertension
• PAH
PART 12: Geographical segmentation
• Global hypertension drugs market by geographical segmentation 2015-2020
• Hypertension drugs market in Americas
• Hypertension drugs market in EMEA
• Hypertension drugs market in APAC
PART 13: Market drivers
• Growing older population
• Rise in sedentary lifestyle
• High prevalence of chronic conditions
• Patient assistance programs
PART 14: Impact of drivers
PART 15: Market challenges
• Patent expiries of major drugs
• Adverse effects
• Poor patient compliance
• Availability of alternative therapies
PART 16: Impact of drivers and challenges
PART 17: Market trends
• Increase in awareness
• Increased focus on combination therapies
• Intense competition among vendors
• Strategic alliances
PART 18: Vendor landscape
• Competitive scenario
• Market share 2015
• Novartis
• Daiichi Sankyo
• Actelion Pharmaceuticals
• Boehringer Ingelheim
• Sanofi
• AstraZeneca
• Other prominent vendors
PART 19: Appendix
• List of abbreviations
PART 20: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Key buying criteria for drugs that treat hypertension
Exhibit 03: Patent expiries of major cardiovascular drugs
Exhibit 04: Global cardiovascular drugs market by generic and branded drugs sales 2015
Exhibit 05: Top 10 companies in global cardiovascular drugs market 2014
Exhibit 06: Pathophysiology of hypertension
Exhibit 07: Treatment algorithm for hypertension
Exhibit 08: Prevalence of PAH by cause
Exhibit 09: Projected prevalence of CVDs in US 2010-2030 (% of population)
Exhibit 10: Prevalence of hypertension in US population 2010-2030 (% of population)
Exhibit 11: Projected direct and indirect burden of hypertension in US 2010-2030 ($ billions)
Exhibit 12: Projected mortality trend for CVDs globally 2015 and 2030
Exhibit 13: Pipeline portfolio: Global systemic hypertension drugs
Exhibit 14: Pipeline portfolio: Global PAH drugs
Exhibit 15: Market share of global hypertension drugs in global pharmaceutical market 2015
Exhibit 16: Global hypertension drugs market 2015-2020 ($ billions)
Exhibit 17: Five forces analysis
Exhibit 18: Global hypertension drugs market segmentation by type 2015
Exhibit 19: Global systemic hypertension drugs market 2015-2020 ($ billions)
Exhibit 20: Global PAH drugs market 2015-2020 ($ billions)
Exhibit 21: Segmentation of global hypertension drugs market by drug class
Exhibit 22: Global systemic hypertension drugs market share by drug class 2015
Exhibit 23: Global PAH drugs market share by drug class 2015
Exhibit 24: Segmentation of global hypertension drugs market based on geography 2015
Exhibit 25: Hypertension drugs market revenue by geography 2015-2020 ($ billions)
Exhibit 26: Percentage share of hypertension drugs market by geography 2015-2020
Exhibit 27: Hypertension drugs market in Americas 2015-2020 ($ billions)
Exhibit 28: Hypertension drugs market in EMEA 2015-2020 ($ billions)
Exhibit 29: Hypertension drugs market in APAC 2015-2020 ($ billions)
Exhibit 30: Global hypertension drugs market: YoY growth rate and revenue based on geography 2015-2020
Exhibit 31: Population aged 60 years and over: World, developed, and developing regions ($ millions)
Exhibit 32: Impact of drivers
Exhibit 33: Impact of drivers and challenges
Exhibit 34: Sales of major drugs in global hypertension drugs market 2014 ($ billions)
Exhibit 35: Novartis: YoY growth rate and revenue of Diovan 2012-2015 ($ billions)
Exhibit 36: Novartis: YoY growth rate and revenue of Exforge 2012-2015 ($ billions)
Exhibit 37: Novartis: Key takeaways
Exhibit 38: Daiichi Sankyo: YoY growth rate and revenue of Olmetec in Japan 2012-2014 ($ millions)
Exhibit 39: Daiichi Sankyo: YoY growth rate and revenue of Olmetec/Olmetec Plus in Europe 2012-2014 ($ millions)
Exhibit 40: Daiichi Sankyo: YoY growth rate and revenue of Rezaltas in Japan 2012-2014 ($ millions)
Exhibit 41: Daiichi Sankyo: YoY growth rate and revenue of Artist in Japan 2012-2014 ($ millions)
Exhibit 42: Daiichi Sankyo: YoY growth rate and revenue of Benicar/Benicar HCT in US 2012-2014 ($ millions)
Exhibit 43: Daiichi Sankyo: YoY growth rate and revenue of AZOR in US 2012-2014 ($ millions)
Exhibit 44: Daiichi Sankyo: YoY growth rate and revenue of TRIBENZOR in US 2012-2014 ($ millions)
Exhibit 45: Daiichi Sankyo: YoY growth rate and revenue of Sevikar in Europe 2012-2014 ($ millions)
Exhibit 46: Daiichi Sankyo: YoY growth rate and revenue of Sevikar HCT in Europe 2012-2014 ($ millions)
Exhibit 47: Daiichi Sankyo: Key takeaways
Exhibit 48: Actelion Pharmaceuticals: YoY growth rate and revenue of Tracleer 2011-2014 ($ billions)
Exhibit 49: Actelion Pharmaceuticals: YoY revenue of Opsumit 2013 and 2014 ($ millions)
Exhibit 50: Actelion Pharmaceuticals: YoY growth rate and revenue of Ventavis 2011-2014 ($ millions)
Exhibit 51: Actelion Pharmaceuticals: YoY growth rate and revenue of Veletri 2011-2014 ($ millions)
Exhibit 52: Actelion Pharmaceuticals: Key takeaways
Exhibit 53: Boehringer Ingelheim: YoY growth rate and revenue of Micardis 2012-2014 ($ millions)
Exhibit 54: Boehringer Ingelheim: Key takeaways
Exhibit 55: Sanofi: YoY growth rate and revenue of Aprovel 2012-2014 ($ millions)
Exhibit 56: Sanofi: YoY growth rate and revenue of Tritace 2012-2014 ($ millions)
Exhibit 57: Sanofi: YoY growth rate and revenue of Lasix 2012-2014 ($ millions)
Exhibit 58: Sanofi: Key takeaways
Exhibit 59: AstraZeneca: Business segmentation by revenue 2015
Exhibit 60: AstraZeneca: YoY growth rate and revenue of Seloken/Toprol 2013-2015 ($ millions)
Exhibit 61: AstraZeneca: YoY growth rate and revenue of Atacand 2013-2015 ($ millions)
Exhibit 62: AstraZeneca: YoY growth rate and revenue of Tenormin 2012-2014 ($ millions)
Exhibit 63: AstraZeneca: Key takeaways
【レポート販売概要】
■ タイトル：高血圧治療薬の世界市場2016-2020■ 英文：Global Hypertension Drugs Market 2016-2020
■ 発行日：2016年4月13日
■ 調査会社：Technavio
■ 商品コード：IRTNTR9233
■ 調査対象地域：グローバル
- 平滑筋肉腫：世界の臨床試験レビュー（2014年上半期）Leiomyosarcoma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Leiomyosarcoma Global Clinical Trials Review, H1, 2014" provides data on the Leiomyosarcoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Leiomyosarcoma. It includes an overview of the trial numbers and their recruitment status as per …
- エンタープライズモビリティ（企業のモバイル管理）のグローバル市場：技術、市場動向Summary This Strategic Focus report analyses the current trends, drivers, and inhibitors impacting the enterprise mobility market. The report outlines the evolution of enterprise mobility technologies, and identifies and assesses the best performing vendors in the market. This report also presents Kable's view of the revenue opportunities in the enterprise mobility management market through to 201 …
- 世界の人工知能（AI）市場：開発、特許動向AI (Artificial Intelligence) plays a pivotal role in IoT (Internet of Things) as it can be applied to a myriad of smart connected products, such as lighting, cars, wearables, medical care, smartphones, and smart home sensing control devices. This report provides an overview of AI technologies and analysis of major vendors' patent deployment and technology development strategies with patent mining …
- ラテンアメリカのバイオインフォマティクス市場動向及び予測（～2017）Bioinformatics is an integration of informatics and life sciences. It uses information technology, statistics, and algorithms for storing, retrieving, and analyzing biological data that is generated during life sciences research. In Latin America, bioinformatics is now widely recognized as a crucial field for research and development in agricultural, veterinary, and human health sciences. Latin Am …
- スポーツ医学における関節修復デバイスの世界市場：肩関節修復、膝関節修復、股関節修復About Sports Medicine Sports medicine refers to a division of the general medicine that concentrates on physical fitness, treatment, and prevention of sports and exercise-related injuries. This division helps in assessing and understanding the performance of athletes. It has been estimated that, each year, around 14% of all medically treated injuries are related to sports. These injuries range fro …
- アメリカの3PL物流サービス市場2016-2020About 3PL Market in the US 3PL is a business process through which companies outsource their logistics and distribution functions to a service provider that specializes in handling logistics functions such as transportation and warehousing. Often, 3PL providers go beyond logistics and provide value-added services such as inventory management, cross-docking, door-to-door delivery, and packaging of …
- 検査ロボットの世界市場2017-2021ABSTRACTAbout Inspection Robots Market Industrial robots are likely to play an integral role across end-user industries (automotive, electronics and electrical and food and beverages) worldwide that are opting for automation of their critical applications to ensure operational efficiency and superior quality products. Inspection robots belonging to the family of industrial robots will subsequently …
- 医薬品包装機械の世界市場予測（～2023年）“The global pharmaceutical packaging equipment market is projected to grow at a CAGR of 7.4%.”The pharmaceutical packaging equipment market is expected to reach USD 8.9 billion by 2023 from an estimated USD 6.2 billion in 2018, at a CAGR of 7.4%. Growth in the generic and biopharmaceutical markets, the growing need for flexible and integrated packaging equipment, the increase in offshore pharmaceu …
- M2M事業戦略と計画（M2M Business Strategy and Planning）We are in the early stages of a new era of the Internet. A big part of this new era will involve the so called "Internet of Things" in which various objects (equipment, machines, electronics, vehicles, appliances, and other assets) communicate with one another and to remote servers via Machine-to-Machine (M2M). However, the M2M market is extremely fragmented and difficult to analyze since most M2M …
- 繊維機械の世界市場2018-2022About Textile Machinery Textile machinery is a sub-classification of machine tools that are used in the production and processing of yarns, fibers, fabrics and cloth. Technavio’s analysts forecast the Global Textile Machinery Market to grow at a CAGR of 8.28% during the period 2018-2022. Covered in this report The report covers the present scenario and the growth prospects of the textile machinery …
- パーソナルアイデンティティー管理の世界市場：アクセス制御、コンテンツ管理、サービスMarketsandMarkets forecasts the Personal Identity Management market size to grow from USD 7.37 Billion in 2016 to USD 12.76 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 11.61%. The constant pressure of managing data breaches along with the need to reduce costs has led enterprises of all sizes to adopt Personal Identity Management applications for data management. Also, cloud-based d …
- Tedatioxetine (大うつ病性障害)：医薬品市場予測及び分析（～2023）Tedatioxetine (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded and competitive market, with more than 30 marketed products available for the treatment of patients with MDD. The depression market is about to enter a dynamic phase with imminent patent expiri …
- コンプレッサーオイルの世界市場2015-2019About compressor and compressor oil Compressors convert mechanical energy to pneumatic energy through compression. They use pistons, vanes, and other mechanisms to compress air and gas to very high pressures. The major types of compressors are PD and centrifugal gas compressors. Compressor oil is used to cool, seal, or lubricate internal components of compressors. The benefits of compressor oil ar …
- 金ナノ粒子の世界市場2015-2019About gold nanoparticles Gold nanoparticles are a colloidal suspension of nanoparticles of gold in water or other liquids. Nanoparticles can be classified as particles that are 1 to 100 nanometers in size. Nanoparticles display properties that are completely different from the properties that they display in bulk. The fluid is generally red in color for particles under 100 nm and blue/purple for p …
- プロピレンの世界市場動向及び予測2015The present report is an essential resource for a one looking for detailed information on the world propylene market. The report covers data on global, regional and national markets including present and future trends for supply and demand, prices, and downstream industries. In addition to the analytical part, the report provides a range of tables and figures which all together give a true insight …
